1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 24 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2006Suppression of androgen receptor signaling in prostate cancer cells by an inhibitory receptor variantButler, L.; Centenera, M.; Neufing, P.; Buchanan, G.; Choong, C.; Ricciardelli, C.; Saint, K.; Lee, M.; Ochnik, A.; Yang, M.; Brown, M.; Tilley, W.
2004Androgen receptor signaling: mechanism of interleukin-6 inhibitionJia, L.; Choong, C.; Ricciardelli, C.; Kim, J.; Tilley, W.; Coetzee, G.
2017Novel selective agents for the degradation of androgen receptor variants to treat castration-resistant prostate cancerPonnusamy, S.; Coss, C.; Thiyagarajan, T.; Watts, K.; Hwang, D.-J.; He, Y.; Selth, L.; McEwan, I.; Duke, C.; Pagadala, J.; Singh, G.; Wake, R.; Ledbetter, C.; Tilley, W.; Moldoveanu, T.; Dalton, J.; Miller, D.; Narayanan, R.
2019A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancerWarren, A.; Massie, C.; Watt, K.; Luko, K.; Orafidiya, F.; Selth, L.; Mohammed, H.; Chohan, B.; Menon, S.; Baridi, A.; Zhao, W.; Escriu, C.; Pungsrinont, T.; D Santos, C.; Yang, X.; Taylor, C.; Qureshi, A.; Zecchini, V.; Shaw, G.; Dehm, S.; et al.
2017The combination of metformin and valproic acid induces synergistic apoptosis in the presence of p53 and androgen signaling in prostate cancerTran, L.N.; Kichenadasse, G.; Butler, L.M.; Centenera, M.M.; Morel, K.L.; Ormsby, R.J.; Michael, M.Z.; Lower, K.M.; Sykes, P.J.
2017Novel androgen receptor coregulator GRHL2 exerts both oncogenic and antimetastatic functions in prostate cancerPaltoglou, S.; Das, R.; Townley, S.; Hickey, T.; Tarulli, G.; Coutinho, I.; Fernandes, R.; Hanson, A.; Denis, I.; Carroll, J.; Dehm, S.; Raj, G.; Plymate, S.; Tilley, W.; Selth, L.
2021Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancerChe, M.; Chaturvedi, A.; Munro, S.A.; Pitzen, S.P.; Ling, A.; Zhang, W.; Mentzer, J.; Ku, S.-Y.; Puca, L.; Zhu, Y.; Bergman, A.M.; Severson, T.M.; Forster, C.; Liu, Y.; Hildebrand, J.; Daniel, M.; Wang, T.-Y.; Selth, L.A.; Hickey, T.; Zoubeidi, A.; et al.
2013Androgen receptor protein levels are significantly reduced in serous ovarian carcinomas compared with benign or borderline disease but are not altered by cancer stage or metastatic progressionButler, M.; Ricciardelli, C.; Tilley, W.; Hickey, T.
2013Ski-interacting protein (SKIP) interacts with androgen receptor in the nucleus and modulates androgen-dependent transcriptionAbankwa, D.; Millard, S.; Martel, N.; Choong, C.; Yang, M.; Butler, L.; Buchanan, G.; Tilley, W.; Ueki, N.; Hayman, M.; Leong, G.
2015Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapiesChan, S.; Selth, L.; Li, Y.; Nyquist, M.; Miao, L.; Bradner, J.; Raj, G.; Tilley, W.; Dehm, S.

Discover